46 results match your criteria: "University of Sydney School of Health Sciences[Affiliation]"
Arch Med Sci
October 2024
Department of Neurology, Shenzhen Qianhai Shekou Free Trade Zone Hospital, Shenzhen City, Guangdong Province, China.
Introduction: The aim of this study was to assess differences in the effects of income level on the primary and secondary prevention of stroke in the Chinese population.
Material And Methods: This was a population-based study using data from a China Kadoorie Biobank survey that began in 2004 in 10 geographical regions. Community residents ( = 512,715) aged 30-79 years were recruited.
Pediatr Surg Int
November 2024
Division of Child and Adolescent Health, Sydney Medical School, The University of Sydney, Sydney, Australia.
Purpose: Congenital diaphragmatic herniae (CDH) may require patch closure in 50% of the cases. We assessed a biologic and composite mesh in a porcine CDH model.
Methods: Left sided thoracotomy was performed in 20 pigs.
Gait Posture
October 2024
University of Sydney School of Health Sciences, Faculty of Medicine and Health, Sydney, NSW, Australia; Paediatric Gait Analysis Service of New South Wales, Sydney Children's Hospitals Network, Westmead, NSW, Australia; St. Jude Children's Research Hospital, Memphis, TN, USA.
Background: Slipped Capital Femoral Epiphysis (SCFE) is femoral head slippage off the femoral neck through the physis occurring in children aged 8-16 years. Surgical intervention is required in all paediatric cases and there is no universal agreement on choice of surgical procedure.
Research Question: What are the two-year 3D gait outcomes in children with SCFE who have undergone in-situ pinning (PIN) or modified Dunn procedure (MDP) compared with normative reference values?
Methods: 17 children with SCFE who had undergone PIN (n=7, slip severity mild to moderate) or MDP (n=10, slip severity moderate to severe) surgical procedures prospectively underwent a 3D gait analysis post-surgery (2∙0 ± 0∙5 years).
Eur Radiol
October 2024
The University of Sydney School of Health Sciences, Sydney, NSW, Australia.
Objectives: Despite showing encouraging outcomes, the precision of deep learning (DL) models using different convolutional neural networks (CNNs) for diagnosis remains under investigation. This systematic review aims to summarise the status of DL MRI models developed for assisting the diagnosis of a variety of knee abnormalities.
Materials And Methods: Five databases were systematically searched, employing predefined terms such as 'Knee AND 3D AND MRI AND DL'.
Physiotherapy
December 2024
Department of Epidemiology and Cancer Control, St. Jude Children's Research Hospital, Memphis, TN, United States.
BMJ Open
October 2024
Faculty of Medicine, Health and Human Sciences, Macquarie University, Sydney, New South Wales, Australia
BMJ Open Sport Exerc Med
October 2024
Greg Brown Diabetes & Endocrine Research Laboratory, Charles Perkins Centre, The University of Sydney Charles Perkins Centre, Sydney, New South Wales, Australia.
Objectives: This study aimed to evaluate the effects of a novel, low-volume combined high-intensity interval training (HIIT) and progressive resistance training (PRT) in overweight/obese adults.
Methods: This randomised control trial compared the effect of regular supervised HIIT combined with PRT (Exercise) with an unsupervised stretching intervention (Control), in previously inactive adults with either normal glucose (NG), pre-diabetes or type 2 diabetes (T2DM) with body mass index of >25 kg/m. Participants were randomly allocated (1:1) to receive low-volume exercise or control by an online randomisation tool.
Dev Med Child Neurol
September 2024
Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
The aim of this longitudinal case series was to describe long-term functional outcome in a group of individuals with riboflavin transporter deficiency (RTD) treated with high-dose oral riboflavin. Data were collected between 2012 to 2022. Eleven individuals with RTD were assessed at 12-month intervals for monitoring of disease progression.
View Article and Find Full Text PDFPediatr Res
August 2024
The University of Sydney School of Health Sciences the University of Sydney, Camperdown, NSW, Australia.
Br J Sports Med
October 2024
The University of Sydney School of Health Sciences, Camperdown, New South Wales, Australia.
J Foot Ankle Res
September 2024
University of Sydney School of Health Sciences & Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Disabil Rehabil
May 2024
Movement Neuroscience Group, School of Exercise and Nutrition Sciences, Queensland University of Technology, Brisbane, Australia.
Purpose: To determine whether short-term wear of textured insoles alters balance, gait, foot sensation, physical activity, or patient-reported outcomes, in people with diabetic neuropathy.
Materials And Methods: 53 adults with diabetic neuropathy were randomised to wear textured or smooth insoles for 4-weeks. At baseline and post-intervention, balance (foam/firm surface; eyes open/closed) and walking were assessed whilst barefoot, wearing shoes only, and two insoles (textured/smooth).
J Peripher Nerv Syst
June 2024
Children's Hospital at Westmead Clinical School, Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales, Australia.
Background And Aims: Riboflavin transporter deficiency (RTD) is a progressive inherited neuropathy of childhood onset, characterised clinically by pontobulbar palsy, sensory ataxia, sensorineural deafness, muscle weakness, optic atrophy and respiratory failure. A robust and responsive functional outcome measure is essential for future clinical trials of disease-modifying therapies including genetic therapies. The Charcot-Marie-Tooth disease Pediatric Scale (CMTPedS) is a well-validated outcome measure for CMT and related neuropathies, and might have utility for measuring disease progression in individuals with RTD.
View Article and Find Full Text PDFHeart Lung Circ
May 2024
Newcastle Centre of Excellence in Cardio-Oncology, The University of Newcastle, Hunter Medical Research Institute, Calvary Mater Newcastle, Newcastle, NSW, Australia; College of Health, Medicine and Wellbeing, The University of Newcastle, Newcastle, NSW, Australia; Cardiovascular Department, John Hunter Hospital, Newcastle, NSW, Australia. Electronic address:
Over 18 million people worldwide were diagnosed with cancer in 2020, including over 150,000 people in Australia. Although improved early detection and treatment have increased the survival rates, cardiotoxic treatment and inadequate management of cardiovascular risk factors have resulted in cardiovascular disease (CVD) being one of the leading causes of non-cancer-related death and disability among cancer survivors. International guidelines outline the standards of care for CVD risk surveillance and management.
View Article and Find Full Text PDFNeurology
February 2024
From the The University of Sydney School of Health Sciences (M.R.M., P.B., K.M.D.C., M.J.M., J.B.), Faculty of Medicine and Health; Sydney Children's Hospitals Network (Randwick and Westmead) (M.R.M., P.B., K.M.C., J.B.), New South Wales, Australia; Department of Neurology (K.J.E., D.N.H.), University of Rochester, NY; Department of Neurology (M.E.S.), Carver College of Medicine, University of Iowa; Centre for Neuromuscular Diseases (M.M.R., G.M.R.), Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, United Kingdom; Department of Neurology (S.S.S.), Perelman School of Medicine at the University of Pennsylvania, Philadelphia; Fondazione IRCCS Istituto Neurologico Carlo Besta (D.P.), Milan, Italy; and The Children's Hospital of Philadelphia, and Perelman School of Medicine at the University of Pennsylvania (T.E.), Philadelphia.
Background And Objectives: Charcot-Marie-Tooth disease type 1A (CMT1A), caused by a duplication of , is the most common hereditary peripheral neuropathy. For participants with CMT1A, few clinical trials have been performed; however, multiple therapies have reached an advanced stage of preclinical development. In preparation for imminent clinical trials in participants with CMT1A, we have produced a Clinical Outcome Assessment (COA), known as the CMT-Functional Outcome Measure (CMT-FOM), in accordance with the FDA Roadmap to Patient-Focused Outcome Measurement to capture the key clinical end point of function.
View Article and Find Full Text PDFInj Prev
November 2023
Discipline of Physiotherapy, Faculty of Medicine and Health, The University of Sydney, Sydney, New South Wales, Australia.
Objectives: To estimate the financial burden of anterior cruciate ligament (ACL) reconstructions in amateur football (soccer) players in Australia over a single year, including both direct and indirect cost.
Methods: Available national direct and indirect cost data were applied to the annual incidence of ACL reconstructions in Australia. Age-adjusted and sex-adjusted total and mean costs (ACL and osteoarthritis (OA)) were calculated for amateur football (soccer) players in Australia using an incidence-based approach.
BJR Open
March 2023
Program Director, Bachelor of Applied Science (Diagnostic Radiography), The University of Sydney School of Health Sciences, Camperdown, Sydney, Australia.
Objective: One of the common modalities used in imaging COVID-19 positive patients is chest radiography (CXR), and serves as a valuable imaging method to diagnose and monitor a patients' condition. Structured reporting templates are regularly used for the assessment of COVID-19 CXRs and are supported by international radiological societies. This review has investigated the use of structured templates for reporting COVID-19 CXRs.
View Article and Find Full Text PDFBrain
October 2023
Department of Neuromuscular Diseases, UCL Queen Square Institute of Neurology, London, WC1N 3BG, UK.
J Peripher Nerv Syst
September 2023
Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Objective: To evaluate the parent-proxy version of the pediatric Charcot Marie Tooth specific quality of life (pCMT-QOL) outcome instrument for children aged 7 or younger with CMT. We have previously developed and validated the direct-report pCMT-QOL for children aged 8-18 years and a parent proxy version of the instrument for children 8-18 years old. There is currently no CMT-QOL outcome measure for children aged 0-7 years old.
View Article and Find Full Text PDFBrain
September 2023
Department of Neurology, University of Rochester, Rochester, NY 14642, USA.
Recessive SH3TC2 variants cause Charcot-Marie-Tooth disease type 4C (CMT4C). CMT4C is typically a sensorimotor demyelinating polyneuropathy, marked by early onset spinal deformities, but its clinical characteristics and severity are quite variable. Clear relationships between pathogenic variants and the spectrum of disease manifestations are to date lacking.
View Article and Find Full Text PDFProsthet Orthot Int
December 2023
Engineering Prototypes & Implants for Children (EPIC) Lab, The Children's Hospital at Westmead, Sydney, New South Wales, Australia.
Background: 3D scanning of the foot and ankle is gaining popularity as an alternative method to traditional plaster casting to fabricate ankle-foot orthoses (AFOs). However, comparisons between different types of 3D scanners are limited.
Objectives: The aim of this study was to evaluate the accuracy and speed of seven 3D scanners to capture foot, ankle, and lower leg morphology to fabricate AFOs.
J Peripher Nerv Syst
June 2023
Department of Neurology, University of Michigan, Ann Arbor, Michigan, USA.
Charcot-Marie-Tooth disease (CMT) reduces health-related quality of life (QOL) in children. We have previously developed and validated the English and Italian versions of the pediatric CMT-specific QOL outcome measure (pCMT-QOL) for children aged 8 to 18. There is currently no parent-proxy CMT QOL outcome measure for use in clinical trials, which could provide complementary information in these children and adolescents.
View Article and Find Full Text PDFBone
February 2023
Bioengineering & Molecular Medicine Laboratory, The Children's Hospital at Westmead and the Westmead Institute for Medical Research, Westmead, NSW, Australia; The Children's Hospital at Westmead Clinical School, The University of Sydney, Camperdown, NSW, Australia. Electronic address:
Purpose: The creation of murine gene knockout models to study bone gene functions often requires the resource intensive crossbreeding of Cre transgenic and gene-floxed strains. The developmental versus postnatal roles of genes can be difficult to discern in such models. For example, embryonic deletion of the Sclerostin (Sost) gene establishes a high-bone mass phenotype in neonatal mice that may impact on future bone growth.
View Article and Find Full Text PDFJ Foot Ankle Res
November 2022
Peninsula Health, Allied Health, Frankston, Victoria, Australia.
J Sports Sci
October 2022
The University of Sydney School of Health Sciences, Discipline of Exercise and Sport Science, Faculty of Medicine and Health, The University of Sydney, Camperdown, Australia.
Analysis of the countermovement jump (CMJ) force-time curve phases provides insight into athlete neuromuscular function and methods by which jump height improves in response to training. A CMJ phase analysis and the dynamic strength index (DSI) have yet to be explored in athletes with cerebral palsy (CP). This study aimed to address this knowledge gap.
View Article and Find Full Text PDF